Company intelligence / Profile preview

Avenir Finance Gestion

Paris, France

Ownership: Private
Development stage: Other

Overview

Avenir Finance Gestion, now operating as part of the Advenis group, is a French asset management and investment firm headquartered in Paris. Historically, the company has been active in private equity and venture capital, frequently investing in small and medium-sized enterprises (SMEs) across the technology and life sciences sectors. While not a biotechnology company itself, it has served as a significant shareholder and financial partner for various European biotech and diagnostic firms, including IntegraGen and Karo Bio. The firm provides wealth management, real estate investment, and fund management services to institutional and private clients.

Industry: Investors

Beyond the preview

Go deeper on Avenir Finance Gestion.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avenir Finance Gestion.

Explore the full profile